GDRX

Goodrx Holdings Inc

GDRX, USA

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

https://www.goodrx.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
GDRX
stock
GDRX

GoodRx approves retention bonuses for CEO and CFO MSN

Read more →
GDRX
stock
GDRX

Barclays Initiates Coverage of GoodRx Holdings (GDRX) with Underweight Recommendation Nasdaq

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$5.0893

Analyst Picks

Strong Buy

7

Buy

1

Hold

7

Sell

1

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Low

35.13

Low 50

High 10

Price to Book Ratio (P/B)

-

Low

1.63

Low 1

High 3

Return on Equity (ROE)

-

Very Low

0.19 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

0.08 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

29.60 %

Low 5%

High 15%

Debt to Equity

-

Very Low

1.21

Low 1

High 0.3

Investors

* Institutions hold a combined 34.62% of the total shares of Goodrx Holdings Inc

1.

Francisco Partners Management LP

(17.2912%)

since

2025/06/30

2.

Vanguard Group Inc

(2.4703%)

since

2025/06/30

3.

Ameriprise Financial Inc

(1.3871%)

since

2025/06/30

4.

Lakewood Capital Management, LP

(1.1965%)

since

2025/06/30

5.

Renaissance Technologies Corp

(1.0357%)

since

2025/06/30

6.

SILVER LAKE GROUP, L.L.C.

(1.0166%)

since

2025/06/30

7.

Petrus Trust Company, LTA

(0.8918%)

since

2025/06/30

8.

Vanguard Total Stock Mkt Idx Inv

(0.7888%)

since

2025/07/31

9.

Dimensional Fund Advisors, Inc.

(0.7189%)

since

2025/06/30

10.

Vanguard Small Cap Index

(0.5953%)

since

2025/07/31

11.

BlackRock Inc

(0.4974%)

since

2025/06/30

12.

Connor Clark & Lunn Inv Mgmt Ltd

(0.4811%)

since

2025/06/30

13.

Technology Crossover Management X, Ltd.

(0.4759%)

since

2025/06/30

14.

Citadel Advisors Llc

(0.4672%)

since

2025/06/30

15.

Rip Road Capital Partners LP

(0.4636%)

since

2025/06/30

16.

State Street Corp

(0.4234%)

since

2025/06/30

17.

Millennium Management LLC

(0.3616%)

since

2025/06/30

18.

Geode Capital Management, LLC

(0.309%)

since

2025/06/30

19.

Vanguard Institutional Extnd Mkt Idx Tr

(0.2736%)

since

2025/07/31

20.

SPDR® S&P Kensho New Economies Comps ETF

(0.2688%)

since

2025/08/29

21.

ClearBridge Advisors, LLC

(0.2456%)

since

2025/06/30

22.

Jacobs Levy Equity Management, Inc.

(0.2386%)

since

2025/06/30

23.

Two Sigma Advisers, LLC

(0.2349%)

since

2025/06/30

24.

ClearBridge Small Cap C

(0.2163%)

since

2025/07/31

25.

ClearBridge Small Cap

(0.2163%)

since

2025/07/31

26.

Two Sigma Investments LLC

(0.2147%)

since

2025/06/30

27.

Columbia Small Cap Value Discv A

(0.2056%)

since

2025/07/31

28.

Columbia Small Cap Value Discovery Fund

(0.1999%)

since

2025/06/30

29.

Vanguard Small Cap Value Index Inv

(0.1928%)

since

2025/07/31

30.

Vanguard Small Cap Growth Index Inv

(0.167%)

since

2025/07/31

31.

Vanguard Strategic Equity Inv

(0.163%)

since

2025/06/30

32.

Fidelity Extended Market Index

(0.1382%)

since

2025/07/31

33.

DFA US Targeted Value I

(0.1334%)

since

2025/07/31

34.

DFA US Small Cap I

(0.1206%)

since

2025/07/31

35.

Schwab US Small-Cap ETF™

(0.1195%)

since

2025/08/30

36.

Dimensional US Targeted Value ETF

(0.1009%)

since

2025/08/29

37.

Vanguard Health Care ETF

(0.0794%)

since

2025/07/31

38.

Dimensional US Small Cap ETF

(0.0745%)

since

2025/08/29

39.

DFA US Micro Cap I

(0.0724%)

since

2025/07/31

40.

T. Rowe Price Integrated US SMCC Eq I

(0.0678%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

EPS Estimate

Latest Release

Date

2025-09-30

EPS Actual

0.08

EPS Estimate

0.0902

EPS Difference

-0.0102

Surprise Percent

-11.3082%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Moderately Defensive(6)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.8)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(3)
Momentum
Strong Momentum(7)
Net Net
Not Undervalued (Net-Net)(3)
Quality
Moderate Quality(4.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.